By Jeff Noll, Global Head of Connected Devices, IQVIA
Digital Health Technologies are becoming more crucial as clinical trials become more patient-centric, spurring a proliferation in technologies geared toward advancing better, more streamlined remote data collection. Advancing technologies that are more familiar, easier to use, and better connected to one another represents a unique challenge for an industry that has, for decades, relied on rigid, highly structured on-site clinical trial designs.
Trial sponsors demand high-quality service, with the greatest breadth of devices to choose from, in order to support increasingly patient-centric, decentralized, and hybrid trials. These solutions must also integrate quickly and seamlessly into study design. In the wake of COVID-19, clinical research has seen an unprecedented acceleration in start-up timelines, creating pressure for trial teams, CROs, and sponsors to move at a faster pace than ever before.
There are a number of challenges that accompany device and technology selection for clinical trials. The steps required to bring the right combination of devices to a study and link them together for optimal data collection and interpretation require expertise, market insight, and streamlined, comprehensive support. As study timeline demands decrease while technology and data types increase, connecting those technologies into a platform that helps trial teams make faster, more informed decisions, benefits the entire study team, from sponsor to site to patients.